Oleclumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Oleclumab
Monoclonal antibody
Type ?
Source Human
Target 5'-nucleotidase
Clinical data
Synonyms MEDI9447
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
Formula C6348H9826N1710O1998S40
Molar mass 143.35 g/mol

Oleclumab (INN[1]) (MEDI9447) is a human monoclonal antibody designed for the treatment of pancreatic and colorectal cancer.

This drug was developed by MedImmune/AstraZeneca.[2]

References[edit]